The revamped and “more anti-vax skewed ACIP committee” at the CDC “has a bone to pick with mRNA vaccines,” according to ...

Gilead Sciences has blamed the low rate of respiratory syncytial virus (RSV) infections last season for ending two midstage ...

This builds upon its initial approval in May 2024 for adults aged 60 years and older, which makes mRESVIA the second approved ...

Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

The FDA has expanded the approval of mResvia to include active immunization in high-risk individuals 18 through 59 years of age.

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Published in the Journal of the American Medical Association (JAMA), the letter says that the dismissal of the advisors and ...

REGINA, SASKATCHEWAN / ACCESS Newswire / June 16, 2025 / Consumer Choice Award (CCA) is proud to announce that Affordable ...

TRNR is expected to have the largest US publicly listed crypto treasury focused on an AI-token TRNR began acquiring $FET in ...

Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has been approved by the US Food and Drug Administration (FDA) ...

Planning Underway for Expedited Follow-up RC and Diamond Programs HIGHLIGHTS 2,882m reverse circulation (RC) drilling ...

New to The Street will continue its coverage with a powerful combination of national TV commercials, long-form interviews, earned media placements, and exposure on iconic outdoor billboards NEW YORK ...